vs
Side-by-side financial comparison of LEXICON PHARMACEUTICALS, INC. (LXRX) and High Roller Technologies, Inc. (ROLR). Click either name above to swap in a different company.
High Roller Technologies, Inc. is the larger business by last-quarter revenue ($6.3M vs $5.5M, roughly 1.1× LEXICON PHARMACEUTICALS, INC.). High Roller Technologies, Inc. runs the higher net margin — 58.4% vs -282.7%, a 341.1% gap on every dollar of revenue. On growth, LEXICON PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (254.4% vs -16.4%).
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Professor Allan Bradley, FRS and Professor Bradley's postdoctoral fellow Arthur T Sands. The company has used its patented mouse gene knockout technology and extensive in vivo screening capabilities to study nearly 5,000 genes in its Genome5000 program and has identified over 1...
S&S – Sansei Technologies is an American company known for its pneumatically powered amusement rides and roller coaster designing.
LXRX vs ROLR — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5M | $6.3M |
| Net Profit | $-15.5M | $3.7M |
| Gross Margin | 96.3% | — |
| Operating Margin | -269.1% | 1.3% |
| Net Margin | -282.7% | 58.4% |
| Revenue YoY | 254.4% | -16.4% |
| Net Profit YoY | 54.0% | 831.9% |
| EPS (diluted) | $-0.04 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5M | — | ||
| Q3 25 | $14.2M | $6.3M | ||
| Q2 25 | $28.9M | $6.9M | ||
| Q1 25 | $1.3M | $6.8M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $1.7M | $7.5M | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | $1.1M | — |
| Q4 25 | $-15.5M | — | ||
| Q3 25 | $-12.8M | $3.7M | ||
| Q2 25 | $3.3M | $-592.0K | ||
| Q1 25 | $-25.3M | $-3.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-64.8M | $-501.0K | ||
| Q2 24 | $-53.4M | — | ||
| Q1 24 | $-48.4M | — |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 99.9% | — | ||
| Q2 25 | 99.9% | — | ||
| Q1 25 | 97.6% | — | ||
| Q4 24 | 77.5% | — | ||
| Q3 24 | 95.9% | — | ||
| Q2 24 | 89.7% | — | ||
| Q1 24 | 97.2% | — |
| Q4 25 | -269.1% | — | ||
| Q3 25 | -85.9% | 1.3% | ||
| Q2 25 | 12.9% | -7.2% | ||
| Q1 25 | -2034.8% | -47.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -3658.4% | -6.3% | ||
| Q2 24 | -3423.3% | — | ||
| Q1 24 | -4147.6% | — |
| Q4 25 | -282.7% | — | ||
| Q3 25 | -90.0% | 58.4% | ||
| Q2 25 | 11.3% | -8.5% | ||
| Q1 25 | -2004.4% | -48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -3722.6% | -6.7% | ||
| Q2 24 | -3304.2% | — | ||
| Q1 24 | -4427.9% | — |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $-0.04 | $0.39 | ||
| Q2 25 | $0.01 | $-0.07 | ||
| Q1 25 | $-0.07 | $-0.39 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.18 | $-0.07 | ||
| Q2 24 | $-0.17 | — | ||
| Q1 24 | $-0.20 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.2M | $2.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $107.5M | $6.6M |
| Total Assets | $185.0M | $16.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.2M | — | ||
| Q3 25 | $116.0M | $2.7M | ||
| Q2 25 | $139.0M | $2.7M | ||
| Q1 25 | $194.8M | $3.5M | ||
| Q4 24 | $238.0M | — | ||
| Q3 24 | $258.4M | $1.3M | ||
| Q2 24 | $310.0M | — | ||
| Q1 24 | $355.6M | — |
| Q4 25 | $107.5M | — | ||
| Q3 25 | $120.2M | $6.6M | ||
| Q2 25 | $129.4M | $2.6M | ||
| Q1 25 | $123.0M | $2.8M | ||
| Q4 24 | $145.9M | — | ||
| Q3 24 | $178.5M | $-779.0K | ||
| Q2 24 | $240.0M | — | ||
| Q1 24 | $288.9M | — |
| Q4 25 | $185.0M | — | ||
| Q3 25 | $205.9M | $16.0M | ||
| Q2 25 | $225.6M | $12.3M | ||
| Q1 25 | $297.7M | $12.8M | ||
| Q4 24 | $298.4M | — | ||
| Q3 24 | $321.1M | $12.9M | ||
| Q2 24 | $373.4M | — | ||
| Q1 24 | $417.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-17.2M | $-78.0K |
| Free Cash FlowOCF − Capex | — | $-90.0K |
| FCF MarginFCF / Revenue | — | -1.4% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | -0.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-17.2M | — | ||
| Q3 25 | $-23.8M | $-78.0K | ||
| Q2 25 | $17.0M | $-840.0K | ||
| Q1 25 | $-43.8M | $-3.6M | ||
| Q4 24 | $-178.8M | — | ||
| Q3 24 | $-53.6M | — | ||
| Q2 24 | $-48.5M | — | ||
| Q1 24 | $-55.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-90.0K | ||
| Q2 25 | — | $-845.0K | ||
| Q1 25 | — | $-3.6M | ||
| Q4 24 | $-179.8M | — | ||
| Q3 24 | $-53.9M | — | ||
| Q2 24 | $-48.8M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.4% | ||
| Q2 25 | — | -12.2% | ||
| Q1 25 | — | -53.5% | ||
| Q4 24 | -11600.7% | — | ||
| Q3 24 | -3097.4% | — | ||
| Q2 24 | -3017.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 17.6% | — | ||
| Q2 24 | 15.5% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.02× | ||
| Q2 25 | 5.23× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LXRX
Segment breakdown not available.
ROLR
| Net Gaming Revenue | $4.9M | 77% |
| Net Revenue Noncore Services | $1.4M | 23% |
